Skip to content

Dichloralphenazone

Published: July 26, 2026Updated: August 24, 2026

Dichloralphenazone is a sedative-hypnotic medication used primarily in the short-term treatment of insomnia and tension headaches. It belongs to the chloral derivative family and produces calming effects on the central nervous system. This medication is typically prescribed when milder sleep aids have proven ineffective.

Quick summary

A sedative-hypnotic medication used for short-term treatment of insomnia and tension relief.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 24, 2026Editorial policy

Key facts at a glance

ATC
N05CC04
RxNorm
22892
Generic
Dichloralphenazone
Class
atc-n05
Brands
—
Availability
rx
Lactation
unknown
Routes
oral
Forms
capsule
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
500mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
250mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
400mg daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose that may cause serious CNS depression and respiratory compromise
Chronic overdose: prolonged use leading to tolerance and dependence
Immediate actions
airway protection, supportive care, activated charcoal if early presentation
Antidote
no specific antidote(supportive care is mainstay of treatment)
Poison Control: 1-800-222-1222

Special Populations

9 groups
✗

pregnancy

first trimester
unsafe
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks

Monitor

regular fetal monitoring

Use of this medication in this population requires careful consideration of risks and benefits.

✗

pregnancy

second third trimester
unsafe
FDA Category
C
Dose Adjustment

avoid

Key Recommendations

avoid use near term due to risk of neonatal CNS depression

Monitor

fetal monitoring and assessment of neonatal withdrawal

Use of this medication in this population requires careful consideration of risks and benefits.

✗

lactation

breastfeeding
unsafe
FDA Category
N
Dose Adjustment

avoid

Key Recommendations

discontinue breastfeeding or avoid drug; excreted in breast milk

Monitor

monitor infant for excessive drowsiness

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

geriatric

elderly
caution
FDA Category
N
Dose Adjustment

reduce dose by 25-50%

Key Recommendations

use lowest effective dose; increased sensitivity to sedative effects

Monitor

monitor for falls, confusion, and excessive sedation

Use with caution and monitor for adverse effects.

✗

pediatric_age

infants children
unsafe
FDA Category
C
Dose Adjustment

avoid in children under 2 years

Key Recommendations

use only in older children when absolutely necessary; avoid in infants

Monitor

close monitoring for respiratory depression and paradoxical reactions

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

renal_impairment

mild moderate
caution
FDA Category
N
Dose Adjustment

reduce dose by 25%

Key Recommendations

use with caution; monitor renal function

Monitor

monitor renal function tests and drug accumulation

Use with caution and monitor for adverse effects.

✗

renal_impairment

severe
unsafe
FDA Category
N
Dose Adjustment

avoid or significantly reduce dose

Key Recommendations

not recommended in severe renal impairment

Monitor

frequent monitoring of renal function and drug levels

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

hepatic_impairment

mild moderate
caution
FDA Category
N
Dose Adjustment

reduce dose by 25-50%

Key Recommendations

use with caution; drug metabolized in liver

Monitor

monitor liver function and for signs of toxicity

Use with caution and monitor for adverse effects.

✗

hepatic_impairment

severe
unsafe
FDA Category
N
Dose Adjustment

avoid

Key Recommendations

avoid in severe hepatic impairment due to impaired metabolism

Monitor

monitor hepatic function and drug levels

Use of this medication in this population requires careful consideration of risks and benefits.

Statistics and clinical data

drug_classWHO
2023

Drug class

Value:Sedative/Hypnotic

Dichloralphenazone is a combination sedative medication

compositionFDA
2023

Composition

Value:Diphenhydramine + Dichloralphenazone

Combination formulation details

usageMedical guidelines
2023

Common uses

Value:Insomnia, Sedation

Therapeutic indications

regulatoryMHRA
2023

Market status

Value:Withdrawn

Regulatory status in multiple countries

Short-term treatment of insomnia, tension headaches, and anxiety-related sleep disturbances.

Produces central nervous system depression through its active metabolites, resulting in sedation and anxiolytic effects similar to other chloral derivatives.

Should only be used short-term due to dependence risk. May cause drowsiness and should be used with caution when operating machinery. Avoid alcohol during treatment. Not recommended for prolonged use without medical supervision.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 24, 2026. · Read our editorial policy